Prostate Cancer Treatment and Research
Prostate Cancer Treatment and Research is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 49k research works in it since 1950. 21.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers represents a comprehensive exploration of advancements in prostate cancer research, covering topics such as androgen receptor signaling, genomic profiling, hormone therapy, immunotherapy, genetic mutations, clinical trials, biomarkers, and molecular biology. The papers discuss the molecular determinants of resistance to antiandrogen therapy, the impact of translocations and gene fusions on cancer causation, and the development of second-generation antiandrogens for the treatment of advanced prostate cancer.
- Prostate Cancer
- Androgen Receptor
- Genomic Profiling
- Hormone Therapy
- Metastatic Prostate Cancer
- Immunotherapy
- Genetic Mutations
- Clinical Trials
- Biomarkers
- Molecular Biology
- Research works
- 49k fractional, since 1950
- In the world top 10%
- 10k per year above
- Top-10% rate
- 21.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +15% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Prostate Cancer Treatment and Research research?
By volume, the United States and China publish the most (2.6k and 1.1k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.6k works
- 2 China 1.1k works
- 3 Germany 471 works
- 4 Italy 400 works
- 5 Japan 396 works
- 6 United Kingdom 351 works
- 7 Canada 304 works
- 8 France 252 works
- 9 India 235 works
- 10 Spain 224 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Prostate Cancer Treatment and Research research?
By volume in 2022–2025, Memorial Sloan Kettering Cancer Center publishes the most Prostate Cancer Treatment and Research research, followed by The University of Texas MD Anderson Cancer Center and Dana-Farber Cancer Institute.
By volume, 2022–2025
- 1 Memorial Sloan Kettering Cancer CenterUnited States 60 works
- 2 The University of Texas MD Anderson Cancer CenterUnited States 51 works
- 3 Dana-Farber Cancer InstituteUnited States 41 works
- 4 University of California, San FranciscoUnited States 39 works
- 5 Johns Hopkins UniversityUnited States 37 works
- 6 Cornell UniversityUnited States 36 works
- 7 University of California, Los AngelesUnited States 34 works
- 8 Harvard UniversityUnited States 31 works
- 9 Istituti di Ricovero e Cura a Carattere ScientificoItaly 31 works
- 10 University of WashingtonUnited States 30 works
Where is Prostate Cancer Treatment and Research research done?
The largest centres of Prostate Cancer Treatment and Research research in 2022–2025 are New York (United States), London (United Kingdom), Shanghai (China) and Beijing (China).
Largest cities, 2022–2025
- 1 New York United States 189 works
- 2 London United Kingdom 150 works
- 3 Shanghai China 136 works
- 4 Beijing China 118 works
- 5 Boston United States 116 works
- 6 Baltimore United States 104 works
- 7 Los Angeles United States 100 works
- 8 Tokyo Japan 91 works
- 9 Seoul South Korea 82 works
- 10 Toronto Canada 81 works
Where is the best place to study Prostate Cancer Treatment and Research?
Among universities, judged by research, Humanitas University, Institute of Cancer Research and Vita-Salute San Raffaele University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Humanitas UniversityItaly | 63.4 | 22.8% | 14.2× | 9 | +223.8% |
| 2 | Institute of Cancer ResearchUnited Kingdom | 61.0 | 24.3% | 60.5× | 16 | +17.6% |
| 3 | Vita-Salute San Raffaele UniversityItaly | 60.5 | 30.7% | 16.0× | 17 | -33.5% |
| 4 | Weill Cornell MedicineUnited States | 55.3 | 18.5% | 15.8× | 17 | — |
| 5 | University of California, San FranciscoUnited States | 55.1 | 20.9% | 7.6× | 39 | +1.1% |
| 6 | Jikei University School of MedicineJapan | 54.0 | 22.4% | 19.1× | 14 | +75.5% |
| 7 | Icahn School of Medicine at Mount SinaiUnited States | 53.4 | 21.1% | 7.4× | 29 | +35.3% |
| 8 | Saarland UniversityGermany | 53.4 | 33.2% | 6.4× | 11 | +83.1% |
| 9 | Karolinska InstitutetSweden | 51.1 | 35.7% | 3.7× | 13 | +8.1% |
| 10 | University of British ColumbiaCanada | 49.8 | 25.3% | 3.6× | 29 | +48.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Prostate Cancer Treatment and Research research growing?
Output in 2018–2022 was 15% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Prostate Cancer Treatment and Research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.